NEW YORK (GenomeWeb News) – Investigators at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) have reeled in an $11.3 million grant from the National Cancer Institute to pursue genome-focused thyroid cancer studies and to fund shared core resources.

Specifically, the NCI funding will support a study that launched in 2008 called "Genetic and Signaling Pathways in Epithelial Thyroid Cancer," which has four integrated components.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."